Reports have suggested a possible link between Co-vaxin and
Reports have suggested a possible link between Co-vaxin and rare events like heart attack (myocardial infarction) or brain stroke, but these claims are not fully proven and remain controversial. For example, a 2024 study from Banaras Hindu University (BHU), published in Springer, followed 926 individuals for one year who had received both doses of Co-vaxin. The study found that around 30% of participants reported AESI (Adverse Events of Special Interest), mostly mild issues such as upper respiratory infections, skin disorders, and menstrual problems. Serious AESI were reported in about 1% of participants, including rare events like stroke and Guillain-Barre syndrome. Importantly, heart attacks were not specifically reported, and the study was observational, meaning it had no control group and no baseline health data prior to vaccination, so it could not definitively link these events to the vaccine.
The study faced significant criticism. The Indian Council of Medical Research (ICMR) labeled it “poorly designed” and rejected it, citing the lack of baseline data, inconsistent definitions of AESI, and inadequacies in the study tools. ICMR warned that the study could be misleading and create a false impression about Co-vaxin’s safety. Bharat Biotech, the manufacturer, also criticized the study, emphasizing that Co-vaxin has an excellent safety record and that rare adverse events are possible with any vaccine. They highlighted that the vaccine has saved millions of lives.
It is important to note that rare serious side effects occur with all vaccines. For example, Covishield (AstraZeneca) has been linked in rare cases to TTS (Thrombosis with Thrombocytopenia Syndrome), which can cause stroke or heart issues, and some cases of myocardial infarction have been reported, though the WHO considers these extremely rare. Moderna and Pfizer (mRNA vaccines) carry a small risk of myocarditis or pericarditis, especially in younger individuals, but a direct link to stroke or heart attack is very uncommon. Sputnik V, a viral vector vaccine similar to Covishield, has also seen rare reports of thrombosis, though it has been used less in India. Overall, studies from institutions like NIH and journals like The Lancet show that COVID vaccines do not increase the risk of heart attack or stroke; in fact, COVID infection itself increases these risks up to 2 times, and vaccination helps reduce them.
In summary, the supposed risk of heart attack or stroke with Co-vaxin comes from a single, criticized study, and there is no confirmed evidence that it is higher than with other vaccines. Rare serious events can occur with all COVID vaccines, but their benefits—protection against COVID and saving millions of lives—far outweigh these risks. Anyone experiencing symptoms such as chest pain, headache, or weakness after vaccination should consult a doctor, but in general, there is no need to panic. For detailed and official information, one can refer to reports from ICMR and WHO.
Comments
Well said!